News

Medivisor Inc.; Reiterated 'Speculative Buy' Rating, Target Price $0.87 by Beacon Equity Research

DALLAS-(Business Wire)-October 2, 2008 - Medivisor Inc. (Pink Sheets: MVSR) has received a reiterated Speculative Buy rating with a price target of $0.87 by Beacon Analyst, Victor Sula, Ph.D.

The full report is available at http://beaconequity.com/main/Page-data/Adpages/Medivisor-Inc.

Anyone interested in receiving alerts regarding MVSR research should e-mail members@beaconequity.com with “MVSR” in the subject line.

In the report, the analyst writes, “MVSR is a medical communications company dedicated to providing concise and timely medical information to healthcare industry professionals. MVSR has several exclusive deals with drug manufacturers to market their products for important shares of profits from drug sales. … The Company is also preparing the launch into the billion dollar energy drink sector. MVSR intends to begin marketing its own targeted energy drink initially throughout the European continent.”

Other companies involved in medical business services include: PDI Inc. (Nasdaq: PDII), inVentive Health Inc. (Nasdaq: VTIV), Omnicom Group Inc. (NYSE: OMC) and Publicis Groupe SA (PUBP.PA).

Beacon Equity Research Disclosure

The analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a wholly owned entity of BlueWave Advisors, LLC, which has been compensated forty three thousand five hundred dollars from Universal Management Services as a marketing budget to manage a comprehensive investor awareness program including the creation and distribution of this report as well as other investor relations efforts. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Please read our report and visit our Web site, BeaconEquity.com, for complete disclosures.

Send this news item to a friend.

Print This Page